CDC: UPDATED, ACIP Votes, October 2016

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to either CDC’s ACIP Home Page or ACIP Meeting Page email subscription service.

The summary of recommendations approved by majority vote of ACIP members at the ACIP meeting of October 19-20 has been updated.

  • For hepatitis B vaccine, ACIP recommended the birth dose within 24 hours of birth for medically stable infants weighing >2,000 grams and born to HBsAg-negative mothers, removal of the permissive language to delay the hepatitis B vaccine birth dose, and approved the revised statement.
  • For meningococcal vaccines, ACIP provided guidance on the updated dosing schedules for one serogroup B meningococcal vaccine, MenB-FHbp (Trumenba). For persons at risk for meningococcal disease and during serogroup B outbreaks, 3 doses of MenB-FHbp administered at 0, 1-2, and 6 months; when given to healthy adolescents not at increased risk for meningococcal disease, 2 doses of MenB-FHbp at 0 and 6 months.

See ACIP Votes, October 2016.

The CDC has reached over 1.2 million email subscribers. Thank you for your support.

Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates

Questions or problems? Please contact support.

Dept of Health and Human Services Logo CDC 24/7 - Saving Lives, Protecting People, Saving Money. CDC.gov/24-7
Learn Vital Information about Dental Sealants Prevent Cavities
CDC on Facebook CDC on Twitter CDC YouTube Channel
Advertisements

CDC: ACIP Votes, October 2016

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to either CDC’s ACIP Home Page or ACIP Meeting Page email subscription service.

This email serves to inform you that recommendations approved by majority vote of ACIP members at the ACIP meeting of October 19-20 are now available. See ACIP Votes, October 2016.

The CDC has reached over 1.2 million email subscribers. Thank you for your support.

Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates

Questions or problems? Please contact support.

Dept of Health and Human Services Logo CDC 24/7 - Saving Lives, Protecting People, Saving Money. CDC.gov/24-7
Learn Vital Information about Dental Sealants Prevent Cavities
CDC on Facebook CDC on Twitter CDC YouTube Channel

ICYMI: Oct 26 CIINC on HPV vaccination recommendations

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Get up-to-date information on HPV vaccination recommendations. The October 26 Current Issues in Immunization NetConference (CIINC) will provide health care professionals an update on the Advisory Committee on Immunization Practices (ACIP) new recommendations for HPV vaccination.

Registration information for the noon ET call can be found at http://www.cdc.gov/vaccines/ed/ciinc/index.html.

.

The CDC has reached over 1.2 million email subscribers. Thank you for your support.

Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates

Questions or problems? Please contact support.

Dept of Health and Human Services Logo CDC 24/7 - Saving Lives, Protecting People, Saving Money. CDC.gov/24-7
Learn Vital Information about Dental Sealants Prevent Cavities
CDC on Facebook CDC on Twitter CDC YouTube Channel

Corrected: HPV Vaccination Update

CDC Vaccine Price List Update: FluLaval

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to CDC’s Vaccine Price List email subscription service.

This message is to notify you that the Vaccine Price List has been updated, with FluLaval NDC 19515-0908-52 added to the Pediatric Influenza list.

.

The CDC has reached over 1.2 million email subscribers. Thank you for your support.

Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates

Questions or problems? Please contact support.

Dept of Health and Human Services Logo CDC 24/7 - Saving Lives, Protecting People, Saving Money. CDC.gov/24-7
Learn Vital Information about Dental Sealants Prevent Cavities
CDC on Facebook CDC on Twitter CDC YouTube Channel

CDC: Preteen & Teen Vaccine Info and Campaign Materials Update

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to CDC’s Preteen & Teen Vaccine website email subscription service. Below is text from a press release issued October 19, 2016, by CDC Media Relations.

Press Release

For Immediate Release

Wednesday October 19, 2016

Contact: Media Relations (404) 639-3286

CDC recommends only two HPV shots for younger adolescents

Fewer shots offer more incentive to prevent HPV cancers

CDC today recommended that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart rather than the previously recommended three doses to protect against cancers caused by human papillomavirus (HPV) infections. Teens and young adults who start the series later, at ages 15 through 26 years, will continue to need three doses of HPV vaccine to protect against cancer-causing HPV infection.

“Safe, effective, and long-lasting protection against HPV cancers with two visits instead of three means more Americans will be protected from cancer,” said CDC Director Tom Frieden, M.D., M.P.H. “This recommendation will make it simpler for parents to get their children protected in time.”

The Advisory Committee on Immunization Practices (ACIP) voted today to recommend a 2-dose HPV vaccine schedule for young adolescents. ACIP is a panel of experts that advises the CDC on vaccine recommendations in the United States. CDC Director Frieden approved the committee’s recommendations shortly after the vote. ACIP recommendations approved by the CDC Director become agency guidelines on the date published in the Morbidity and Mortality Weekly Report (MMWR).

CDC and ACIP made this recommendation after a thorough review of studies over several meetings. CDC and ACIP reviewed data from clinical trials showing two doses of HPV vaccine in younger adolescents (aged 9-14 years) produced an immune response similar or higher than the response in young adults (aged 16-26 years) who received three doses.

Generally, preteens receive HPV vaccine at the same time as whooping cough and meningitis vaccines. Two doses of HPV vaccine given at least six months apart at ages 11 and 12 years will provide safe, effective, and long-lasting protection against HPV cancers. Adolescents ages 13-14 are also able to receive HPV vaccination on the new 2-dose schedule.

CDC will provide guidance to parents, healthcare professionals, and insurers on the change in recommendation. On October 7, 2016, the U.S. Food and Drug Administration (FDA) approved adding a 2-dose schedule for 9-valent HPV vaccine (Gardasil® 9) for adolescents ages 9 through 14 years. CDC encourages clinicians to begin implementing the 2-dose schedule in their practice to protect their preteen patients from HPV cancers.

ACIP, CDC, FDA and partners monitor vaccines in use in the U.S. year-round. These updated recommendations are an example of using the latest available evidence to provide the best possible protection against serious diseases.

###

U.S. Department of Health and Human Services

The CDC has reached over 1.2 million email subscribers. Thank you for your support.

Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates

Questions or problems? Please contact support.

Dept of Health and Human Services Logo CDC 24/7 - Saving Lives, Protecting People, Saving Money. CDC.gov/24-7
Learn Vital Information about Dental Sealants Prevent Cavities
CDC on Facebook CDC on Twitter CDC YouTube Channel

HPV Vaccination Update